Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy

American Heart Journal

Volumn 155, Issue 6, 2008, Pages 1128-1134

  Bos, J Martijn ^a   Theis, Jeanne L ^a   Tajik, A Jamil ^a   Gersh, Bernard J ^a   Ommen, Steve R ^a   Ackerman, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MUSCLE RESECTION; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; GENETIC HETEROGENEITY; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 44149114286     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.01.005     Document Type: Article

References (29)

1. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
2. Maron B.J., and Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 114 (2006) 1633-1644
3. Jarcho J.A., McKenna W., Pare J.A., et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 321 (1989) 1372-1378
4. Geisterfer-Lowrance A.A., Kass S., Tanigawa G., et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62 (1990) 999-1006
5. Lever H.M., Karam R.F., Currie P.J., et al. Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation 79 (1989) 580-589
6. Solomon S.D., Wolff S., Watkins H., et al. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 22 (1993) 498-505
7. Binder J., Ommen S.R., Gersh B.J., et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 81 (2006) 459-467
8. Dimitrow P.P., Czarnecka D., Kawecka-Jaszcz K., et al. The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol 88 (2003) 11-16 [discussion 16-7]
9. Maron B.J., Casey S.A., Hurrell D.G., et al. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. Am J Cardiol 91 (2003) 1195-1198
10. Maron B.J., Casey S.A., Hauser R.G., et al. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol. 42 (2003) 882-888
11. Olivotto I., Maron M.S., Adabag A.S., et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 480-487
12. Van Driest S.L., Vasile V.C., Ommen S.R., et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 1903-1910
13. Van Driest S.L., Ellsworth E.G., Ommen S.R., et al. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 108 (2003) 445-451
14. Van Driest S.L., Jaeger M.A., Ommen S.R., et al. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 602-610
15. Vasile V.C., Ommen S.R., Edwards W.D., et al. A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy. Biochem Biophys Res Commun 345 (2006) 998-1003
16. Vasile V.C., Will M.L., Ommen S.R., et al. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol Genet Metab 87 (2006) 169-174
17. Theis J.L., Bos J.M., Bartleson V.B., et al. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem Biophys Res Commun 351 (2006) 896-902
18. Bos J.M., Poley R.N., Ny M., et al. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab 88 (2006) 78-85
19. Van Driest S.L., Ommen S.R., Tajik A.J., et al. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 80 (2005) 463-469
20. Bos J., Ommen S., and Ackerman M. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?. Curr Opin Cardiol 22 (2007) 193-199
21. Krumholz H.M., Larson M., and Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol 72 (1993) 310-313
22. Carroll J.D., Carroll E.P., Feldman T., et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86 (1992) 1099-1107
23. Kostkiewicz M., Tracz W., Olszowska M., et al. Left ventricular geometry and function in patients with aortic stenosis: gender differences. Int J Cardiol 71 (1999) 57-61
24. Jain M., Liao R., Podesser B.K., et al. Influence of gender on the response to hemodynamic overload after myocardial infarction. Am J Physiol Heart Circ Physiol 283 (2002) H2544-H2550
25. Perkins M.J., Van Driest S.L., Ellsworth E.G., et al. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur Heart J 26 (2005) 2457-2462
26. Malhotra A., Buttrick P., and Scheuer J. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol 259 3 Pt 2 (1990) H866-H871
27. Maron M.S., Olivotto I., Zenovich A.G., et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 (2006) 2232-2239
28. Shah J.S., Tome Esteban M.T., Thaman R., et al. Prevalence of exercise induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart (2007) [electronic publication ahead of print]
29. Maron B.J. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 116 (2007) 196-206 [discussion 206]